Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 11072792
Materials and methods for treatment of usher syndrome type 2A
granted -
US 11071755
Materials and methods for engineering cells and uses thereof in immuno-oncology
granted -
US 11073523
Method for differentially diagnosing ACTH-dependent Cushing's syndrome
granted -
US 11071729
1′,3′-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2H,1′H-[1,4′]bipyridinyl-2′-ones
granted -
US 11072794
Compositions and their uses directed to huntingtin
granted -
US 11072656
Anti-CD3 antibodies, bispecific antigen-binding molecules that bind CD3 and CD20, and uses thereof
granted -
CA 3161101
TRAITEMENT DE L'HYPOPARATHYROIDISME
granted -
US 11066647
Pluripotent human adipose adult stem cells: isolation, characterization and clinical implications
granted -
US 11065199
Devices and methods for treating ear pain
granted -
US 11066420
Inhibitors of low molecular weight protein tyrosine phosphatase (LMPTP) and uses thereof
granted -
US 11065284
Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
granted -
US 11065347
Methods for the treatment of Danon disease and other disorders of autophagy
granted -
US 11065262
Topical treatment of wounds with statins and cholesterol for scar reduction
granted -
US 11065223
Antimicrobial compositions and uses thereof
granted -
US 11066458
VEGF antagonist formulations suitable for intravitreal administration
granted -
US 11066667
Organic compositions to treat APOC3-related diseases
granted -
US 11066674
Chimeric antigen receptors targeting b-cell maturation antigen
granted -
US 11066670
Insulin-like growth factor binding protein, acid labile subunit (IGFALS) and insulin-like growth factor 1 (IGF-1) iRNA compositions and methods of use thereof
granted -
US 11066666
Bioactive renal cells
granted -
US 11066656
PH20 polypeptide variants, formulations and uses thereof
granted -
US 11066679
Closed-ended linear duplex DNA for non-viral gene transfer
granted -
US 11066481
Antibodies to coagulation factor XIa and uses thereof
granted -
US 11066479
Monoclonal antibodies targeting glypican-2 (GPC2) and use thereof
granted -
US 11066474
Anti-TrkB monoclonal antibodies and methods of use
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.